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College students are at elevated risk for depression due to the unique stressors of 
this developmental stage. Among potential biomarkers, there has been a strong interest in 
respiratory sinus arrhythmia (RSA), a measure of parasympathetic influences on cardiac 
activity. Research suggests resting RSA may mark individual differences in self-
regulation abilities and higher levels of resting RSA indicate increased physiological 
flexibility and self-regulation capacity. However, the precise relation between RSA and 
depression is inconsistent in the adult literature. We investigated the association between 
resting RSA and depressive symptoms across approximately 1 year in an emerging adult 
sample (n = 185). We hypothesized that lower resting RSA at year one (Y1) would 
predict higher depressive symptoms at Y2. Results indicate Y1 resting RSA is indeed 
associated with Y2 depressive symptoms in emerging adults, even after controlling for 
several confounding variables. Findings provide support for RSA as a promising 
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College students are at elevated risk for depression due to the unique stressors of 
this developmental stage (e.g., increased autonomy, academic pressures, and changes to 
social support networks; Hirsch, Webb, & Jeglic, 2011; Rawson, Bloomer, & Kendall, 
1994). Indeed, even though college is perceived to be a time of intellectual and 
interpersonal growth, many students report heightened distress during this time 
(Eisenberg, Gollust, Golberstein, & Hefner, 2007). When surveyed, many university 
students describe problems with grades, finances, relationships, and feelings of 
loneliness, hopelessness, and helplessness (Furr, Westefeld, McConnell, & Jenkins, 
2001). According to the American College Health Association, approximately 10% of 
college students meet criteria for major depressive disorder (MDD; National College 
Health Assessment, 2010). Some young adults also show worsening depression during 
this stage (Fisher & Hood, 1987), which may indicate a more protracted form of the 
disorder, heightened risk for suicide, or a more severe clinical course. Thus, identifying 
predictors of depressive symptoms could lead to earlier identification or targeted 
prevention of MDD for adults attending college. 
 
RSA as a Biological Marker of Depression 
 
Over the past several decades, scientists have sought to identify biomarkers of 
depression and depressive symptoms (Cowen & Wood, 1991; Gentzler, Rottenberg, 





Shelton, & Duman, 2011). Among potential biomarkers, there has been a strong interest 
in respiratory sinus arrhythmia (RSA, known alternatively as cardiac vagal control, vagal 
tone, or high-frequency heart-rate variability; Rottenberg, 2007), a measure of 
parasympathetic influence on cardiac activity. RSA is the beat-to-beat variability in heart 
rate that corresponds with the breathing cycle in which inhalation suppresses vagal 
activity and increases heart rate, and exhalation resumes vagal activity and decreases 
heart rate. When an individual is at rest, higher resting RSA indicates conservation of 
resources and is therefore considered adaptive. Research findings also suggest resting 
RSA may mark individual differences in self-regulation abilities (Beauchaine, 2001; 
Porges, 1995, 2007). Specifically, higher levels of resting RSA appear to indicate 
increased physiological flexibility, self-regulation capacity, and ability to adapt when 
faced with environmental stressors (Porges, 1995, 2007). 
 The interest in RSA as a potential marker of depression follows from a growing 
literature examining the relation between RSA and several other physical and mental 
health outcomes. For example, high RSA is associated with social competence 
(Eisenberg et al., 1995) resilience among individuals faced with stressors (Fabes & 
Eisenberg, 1997), and the ability to respond flexibly to environmental demands (Porges, 
2007). Alternatively, low levels of resting RSA are associated with several disorders and 
problems in children and adults, including poor impulse control (Beauchaine, 2001), 
anxiety (Thayer, Friedman, & Borkovec, 1996), as well as negative health conditions, 
such as cardiovascular disease (Hinkle, Carver, & Plakun, 1972) and sudden cardiac 
death following myocardial infarction (Peltola et al., 2008).  
 However, the precise relation between RSA and depression is less clear. In 
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several studies, low resting RSA is associated with higher depression or more depressive 
symptoms, as would be expected. In one such study, Gentzler and colleagues (2012) 
followed children between the ages of 5-14 at high risk for MDD, defined as having a 
parent with a childhood-onset mood disorder. The high-risk group did not show the same 
developmental increase in resting RSA as the low risk group. This suggests that young 
people at risk for depression demonstrate an atypical trajectory of resting RSA over time. 
Another study examined RSA as a marker of emotion dysregulation in a sample of 8-12 
year old children and found that lower resting RSA was associated with depression (Pang 
& Beauchaine, 2012). Moreover, in a large sample of adults diagnosed with MDD the 
authors found the expected association between depression and decreased RSA. 
However, the authors were not able to rule out a possible effect of medications (Licht et 
al., 2008).  
In spite of theoretical and empirical evidence that depression should be associated 
with lower resting RSA, adult findings are not consistent. Lehofer and colleagues (1997) 
investigated parasympathetic influences on heart rate in individuals diagnosed with MDD 
compared with age and sex matched controls and found no resting RSA differences. RSA 
has also been examined as a predictor of MDD severity and recovery (Rottenberg, 
Wilhelm, Gross, & Gotlib, 2002) in a sample of 55 adults, all of whom were diagnosed 
with MDD. The researchers found that resting RSA was not related to depression 
severity, but was positively associated with sadness and negatively associated with 
suicidality (i.e., lower RSA correlated with higher suicidality). Paradoxically, higher 
levels of resting RSA at year one (Y1) predicted a more malignant course of depression 
by year two (Y2). Given these inconsistent findings, Rottenberg (2007) conducted a 
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meta-analysis to determine the relation between depression and RSA across 13 studies. 
This meta-analysis revealed a small to moderate effect in both healthy participants (d = 
0.33) and participants with compromised cardiovascular functioning (d = 0.28), with 
lower RSA corresponding to higher depression.   
In sum, lower RSA is a promising marker for depression but the findings are 
inconsistent. Possible reasons for this include the presence of comorbid disorders such as 
anxiety, medication effects, and physical health (Molgaard, Hermansen, & Bjerregaard, 
1994; Rottenberg, et al., 2007). Specifically, anxiety, poor physical health (e.g., obesity), 
and certain medications are also associated with low resting RSA (Watkins, Grossman, 
Krishnan, & Blumenthal, 1999), leading researchers to question whether the association 
between resting RSA and depressive symptoms may be driven by these other factors 
(Molgaard, et al., 1994). Disregarding these variables could produce inconsistent 
estimates of the association between RSA and depression. 
In addition, most of the previous studies are cross-sectional, which precludes tests 
of the temporal association between resting RSA and depressive symptoms. Ideally, 
biomarkers such as RSA could serve as a predictor of later depression, which could 
improve early intervention and prevention efforts. Finally, most studies have examined 
the association between RSA and depressive symptoms in smaller clinical samples. 
Examining only one extreme of the distribution neglects the continuum of depressive 
symptoms and could produce unexpected associations between these variables 
(Beauchaine, 2009). Thus, the role of RSA as a predictor of depressive symptoms in a 
normative adult sample is not well understood, suggesting a strong need for longitudinal 
research (Berntson, Cacioppo, & Grossman, 2007). 
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The Current Study 
 
      In the current study, we examine the association between resting RSA and 
depressive symptoms in a large sample of college students over a 12-month time period. 
In contrast to prior research, we have assessed several covariates that may have clouded 
the relation between these variables previously, including anxiety, body mass index 
(BMI), and use of psychiatric medication. We also measured resting RSA and depressive 
symptoms at two time points approximately 12 months apart. This allowed us to examine 
the longitudinal association between resting RSA and depressive symptoms during a 
developmental stage in which psychopathology often increases. We hypothesized that 
lower resting RSA would be associated with higher depressive symptoms scores at both 
time points (Y1 and Y2). Further, we hypothesized that lower levels of Y1 RSA would 
predict higher Y2 depressive symptoms. Importantly, because both RSA and depression 
show high stability over time (Beauchaine, Neuhas, Brenner, & Gatzke-Kopp, 2008; 
Sloan, Shapiro, Bagiella, Gorman, & Bigger, 1995), we tested a model where Y1 RSA 
predicted Y2 depressive symptoms while accounting for the stability in RSA and 
depressive symptoms across the two time points.











At year one, 371 college students were recruited through a psychology department 
participant pool. Of those, 336 provided consent for future contact and were therefore 
considered eligible for the longitudinal component of the study. These individuals were 
contacted approximately 12 months after their Y1 visit and invited to participate in the 
study follow-up. Due to the presence of nontraditional students at the university, we 
made no age restrictions for the study. However, as expected, the majority of the 
participants were young adults (mean age = 25; mode = 23). Given the wide age range 
(18-64), age was also included as a covariate in statistical models.  
All components of this study were approved by the institutional review board. 
Participants were included if they were 18 years of age or older and attending the 
University of Utah. Exclusion criteria included a history of seizures or other neurological 
conditions that could be exacerbated by 3D stimuli (used for another aspect of the study 
protocol; reported elsewhere). Participants were not excluded for use of beta-blockers or 
psychiatric medication; however, medication use was noted and later controlled for in the 
model. Upon meeting eligibility criteria, participants were assessed at two time points 
approximately 12 months apart. Participants were initially recruited through the 
university participant pool, then invited to participate in the Y2 follow-up visit using  
methods that participants selected in their Y1 consent form, including (1) mailing flyers; 
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 (2) phone calls; and (3) e-mails. Interested participants were asked to contact study 
personnel by phone or e-mail to schedule an appointment. Participants were compensated 
with 3 hours of research credit at Y1, and given two options for compensation at Y2: (1) 




Year 1 Visit 
Participants were seated in a quiet, comfortable room. Once consent was obtained, 
participants were asked to complete the Beck Depression Inventory II (BDI-II; Beck, 
Steer, & Brown, 1996), a demographics form (e.g., age, height, weight, ethnicity, etc.), 
and several self-report questionnaires related to depression, emotion regulation, and 
psychopathology (described below). Next, a brief video was shown to inform participants 
of the electrode placement and describe the physiology equipment used in the study. A 
research assistant who was matched to the participant’s sex then placed electrodes before 
obtaining resting RSA for the last minute of a 5 min resting period. At the end of the 
study visit, the electrodes were removed and participants were debriefed and 
compensated. Participants completed an IRB-approved re-contact form to either decline 
or provide consent for future contact. 
 
Year 2 Visit  
 
After consent was obtained, participants were asked to complete the Beck 
Depression Inventory (BDI-II) used to identify and measure depressive symptoms. 
Participants were then shown the video used at Y1 describing electrode placement and an 
identical protocol was used to obtain resting RSA. Participants were assessed in the same 
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room for both Y1 and Y2 and all equipment, hardware, and software were identical. 
Participants also completed questionnaires related to demographics, and completed other 
self-report measures initially given at Y1. Participants were then debriefed, compensated, 




Participants were asked to complete a battery of self-report questionnaires 
regarding symptoms of depression and anxiety, and a demographics form. Resting RSA 
was collected during the same study session.  
  
Self-Report Measures  
 
The Demographics Form is a brief multiple choice and free response self-report 
form in which we collected data on participant age, biological sex, height and weight 
(later used to calculate BMI), and medication use over the prior 2 weeks. A measuring 
tape and scale were provided to facilitate accurate reporting of height and weight. 
Participants were asked to list all medications taken in the past 2 weeks leading up to the 
visit date. Consistent with other psychophysiological studies, the following medications 
were presumed to affect physiological responding: beta-blockers, antihistamines, tricyclic 
antidepressants, stimulants, and seizure medication (Cacioppo, Tassinary & Berntson, 
2007). Tests of our primary hypotheses were conducted with and without these 
participants to determine whether effects were due to medication use. 
The Beck Depression Inventory-II (Beck, Steer & Brown, 1996) is a 21-item 
questionnaire used to measure the severity of depression by assessing cognitive, 
affective, behavioral, and physiological symptoms. The BDI-II is a widely used 
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instrument that has been shown to have good test-retest reliability (r = 0.93, p < .001), 
moderate to high convergent validity with the Short Form General Health Survey (r = -
.19 to -.65), and high internal consistency (r = .54 to .74).  The instrument is not used to 
diagnose depression, but rather to identify depressive symptoms that are consistent with 
diagnostic criteria. Responses on the BDI-II are rated from 0 (low intensity) to 3 (high 
intensity). Scores range from 0-63 with higher scores indicating higher depressive 
symptoms. Total scores of 0-13 are considered in the minimal range, 14-19 is mild, 20-28 
is moderate, and 29-63 scores of are considered severe. 
The State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch, & Lushene, 
1970) is an instrument used to help diagnose anxiety and a general propensity to being 
anxious. The STAI has two subscales (state anxiety and trait anxiety) with 20 items each. 
The STAI defines trait anxiety as the stable aspects or qualities of anxiety rather than a 
temporary condition. Items are on a 4-point scale from Almost Never to Almost Always, 
where higher scores on the STAI indicate greater anxiety. Internal consistency 
coefficients range from .86 to .95, and test-retest reliability coefficients range from .65 to 
.75. Although the STAI examines state and trait anxiety, we selected trait anxiety for our 





Psychophysiological assessments were conducted in a sound attenuated room that 
was monitored with audio-video recording equipment. Electrodes were placed on the 
participant’s torso using a standard spot configuration (Qu, Zhang, Webster, & 
Tompkins, 1986). The ECG signal was sampled at 1 kHz. RSA was measured for the last 
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2 min of a 5 min resting period using a MindWare BioNex 3711-08 chassis and 
MindWare Biolab 3.0.9 acquisition software (MindWare Technologies, Ltd., Gahanna, 
OH, USA). Physiological data were scored in 30-second epochs and averaged to create a 
single resting RSA score for each time point. R-wave markers were evaluated for artifacts 
through visual inspection, and were corrected manually. In order to examine the 
parasympathetic influences on heart rate variability, spectral analysis was performed with 
MindWare software and all variables were log transformed by the software to reduce 


























     At Y1, a total of 363 participants took part in the study. Resting RSA data from 
15 participants were unusable due to experimenter mistake or equipment failure. Two 
hundred and twenty nine participants (63% of eligible participants) participated in a 
component of the Y2 follow-up approximately 12 months later. Of these 229 participants, 
44 either declined to return to the laboratory for the physiological component of the study 
or RSA scores were unusable due to equipment failure. All 229 participants at Y2 
consented to completing online questionnaires related to demographics, mood, emotion 
and psychopathology. Thus, data at Y2 are available for 229 participants for self-report 




     At Y1, participants were 63% female, 86% Caucasian, and between the ages of 
17-63 (M = 23.71, SD = 6.42). At year two, participants were 61% female, 90% 
Caucasian, and between the ages of 19-64 (M = 24.15, SD = 5.77). Table 1 summarizes 
additional participant information at year one and year two including height, weight, 
body mass index (BMI), medication use, resting RSA levels and BDI scores. In order to 
test whether there were significant differences between the participants at year one and 
those who returned for year two, a series of t-tests were performed. Results indicate no 




significant differences between Y1 and Y2 emerged for resting RSA levels, t(391) = -
5.48, p <.001, and BDI scores, t(405) = 4.39, p <.001. That is, resting RSA scores at Y1 
were significantly lower than resting RSA scores at Y2, and BDI scores at Y1 were 
significantly higher than BDI scores at Y2. This suggests that participants with the lowest 
RSA and highest depression scores were also the least likely to return for follow-up.  
 
Preliminary Analyses     
 
Data were analyzed using SPSS, version 20.0 (SPSS Inc, Armonk, New York). 
Characteristics across participants at Y1 and those who returned at Y2 were compared 
using one sample t-tests and chi square statistics. Prior to conducting analyses, we 
performed correlations in order to examine the cross sectional associations between 
resting RSA and depressive symptoms at each time point, and to assess stability between 
Y1 and Y2 variables (see Table 2). Correlations indicated that Y1 resting RSA was 
negatively associated with Y1 depressive symptoms (r = -.11, p <.05), as predicted. 
However, Y2 resting RSA was not associated with Y2 depressive symptoms. Across the 
two time points, Y1 and Y2 resting RSA were highly correlated (r = 0.50, p <.001), as 
were Y1 and Y2 BDI (r = 0.60, p <.001).  
We also performed correlations to examine associations between Y1 resting RSA 
and potential confounding variables including age, body mass index, and comorbid 
anxiety. Y1 age was negatively associated with Y1 RSA (r = -.31, p < .001) and therefore 
added to the model to control for effects. In addition, BMI was included as one estimate 
of physical health. Y1 BMI was negatively associated with Y1 resting RSA (r = -.11, p 
<.05) and was also included in the model to control for effects. Symptoms of trait anxiety 
were assessed using Y1 STAI responses. Correlations indicated a strong association 
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between trait anxiety and depressive symptoms at Y1 (r = .78, p < .001) and Y2 (r = .53, 
p < .001), and with Y1 resting RSA (r = -.11, p < .05).  
 




A regression analysis was performed to test the hypothesis that lower resting RSA 
at Y1 predicts higher depressive symptoms (BDI-II score) at Y2. To account for the 
stability in depressive symptoms, BDI-II scores at Y1 were included in the model in 
order to control for baseline depressive symptoms. BDI-II scores at Y2 were regressed 
onto resting RSA at Y1 (see Figure 1). As hypothesized, a significant negative 
association emerged between Y2 BDI-II and resting RSA at Y1 (B = -0.92, Beta = -.16, p 
= 0.02), indicating that individuals with lower resting RSA at Y1 showed higher 
depressive symptoms at Y2 while accounting for the stability in both scores over time 
(see Figure 2). The model accounted for 46% of the variance in Y2 depressive symptoms, 
F (3, 172) = 48.08, p <.001, R2 = 0.46.    
     To assess potential effects of age, BMI and trait anxiety (all measured at Y1), 
these variables were included in the model as predictors of Y2 depressive symptoms. 
Results indicated none of these variables were significant predictors of Y2 depressive 
symptoms (all ps > .05). In order to examine the effects of medication on the association 
between resting RSA and depressive symptoms, we first ran the model with all 
participants regardless of medication use. Because medication use was measured 
dichotomously (yes or no) and dosages were not assessed, we chose to re-run this model 
excluding participants who reported medications use with known effects on 
psychophysiology (e.g., beta-blockers, tricyclic antidepressants, antihistamines, 
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stimulants and benzodiazepines). This analysis indicated that the association between Y1 
resting RSA and Y2 depressive symptoms was maintained even after excluding 







Demographics for Participants at Year One and Year Two 
 
       _  ____ Year 1_____     _____    Year 2_____ 















85.8% --  90.3% --  
Height (in) 67.6(4.1) 58-81  67.7(4.0) 
 
58-78  
Weight (lbs) 155.1(47.5) 95-370  156.1(35.9) 97-400  
 





6.2(1.4) 0.9-13.1  6.5(1.2)* 2.9-9.5  















Correlations between Variables Across Both Time Points 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 
 
1. RSA1 - .50*** -.11* -.15* -.31** -.10 .00 -.11* .10* -.04 -.10 -.08 -.07 -.11 
 
2. RSA2 .50** - -.04 -.04 -.25** .05 -.01 .08 .15* -.01 .04 -.04 .08 -.08 
 
3. BDI1 -.11* -.04 - .60*** .02 .08 -.02 .10 .10 -.02 .07 -.03 .11 .12 
 
4. BDI2 -.15* -.04 .60*** - -.08 .05 -.11 .13* .02 .12 .12 -.08 .19* .22** 
 
5. Age1 -.31*** -.25** .02 -.08 - .25*** .08 .26*** .05 .08 .30*** .14 .27*** .02 
 
6. WT1 -.10 .05 .08 .05 .25*** - .59*** .86*** .07 .02 .94*** .49*** .80*** -.04 
 
 7. HT1 -.00 -.01 -.02 -.11 .08 .59*** - .09 -.06 -.03 .54*** .84*** .12 -.12 
 
 8. BMI1 -.11* .08 .10 .13* .26*** .86*** .09 - .12* .06 .80*** .09 .89*** .03 
 
9. Rx1 .10* .15* .10 .02 .05 .07 -.06 .12* - -.05 .07 .01 .08 -.06 
 
10.Age2 -.04 -.01 -.02 .12 .08 .02 -.03 .06 -.05 - -.00 -.08 .05 -.02 
 
11.WT2 -.10 .04 .07 .12 .30*** .94*** .54*** .80*** .07 -.00 - .52*** .86*** -.06 
 
12. HT2 -.08 -.04 -.03 -.08 .14 .49*** .84*** .09 .01 -.08 .52*** - .01 -.15* 
 
13.BMI2 -.07 .08 .11 .19* .27*** .80*** .12 .89*** .08 .05 .86*** .01 - .02 
 
14.Rx2 -.11 -.08 .12 .22** .02 -.04 -.12 .03 -.06 -.02 -.06 -.15* .02 - 
 
Note. 1 & 2 correspond with year data was collected. RSA- Resting respiratory sinus arrhythmia, BDI – Beck Depression Inventory 
year one, WT- weight, HT- height, BMI- Body mass index, Rx- Medications currently taking.  
*p <.05.  **p <.01 ***p <.001 
 


















    
    

















































Resting RSA level has often been interpreted as an index of physiological 
flexibility and self-regulatory capacity; however, prior research demonstrates mixed 
findings for the association between RSA and psychopathology. In this study, we 
investigated whether resting RSA predicted depressive symptoms across a 12-month 
period while accounting for the stability in RSA and depressive symptoms over time. 
Consistent with our primary hypothesis, we found that resting RSA was negatively 
associated with BDI at Y1. We also found that lower resting RSA at Y1 predicted higher 
depressive symptoms at Y2 after controlling for effects of age, BMI, symptoms of 
anxiety, and medication use. However, the cross-sectional association between RSA and 
BDI was not significant at Y2. We suspect this is due to the fact that participants with 
more moderate to severe depressive symptoms did not return for the follow-up visit. 
Unlike several other studies, we examined potential confounds of this association 
including age, BMI, use of specific psychiatric medications, and symptoms of anxiety. 
Previous research has recommended identifying and controlling for these variables when 
examining associations between RSA and depressive symptoms (Rottenberg, 2007). 
Including these variables in our model indicates that the association between Y1 resting 
RSA and Y2 depressive symptoms in this sample is not likely due to effects of age, BMI, 
symptoms of anxiety, or medication use. Symptoms of anxiety were also positively 
associated with depressive symptoms at both time points; however, trait anxiety was not a 
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significant predictor of later depressive symptoms with Y1 RSA in the model.  
Many scholars hypothesize that RSA is a biomarker of emotion dysregulation and 
may mark risk for a range of clinical diagnoses (e.g., Austin, Riniolo, & Porges, 2007; 
Crowell et al., 2005; Pang & Beauchaine, 2012). In most studies, RSA is assessed cross-
sectionally or in clinical samples. Fewer studies have examined RSA as a predictor of 
later depressive symptoms in a young, healthy, nontreatment seeking sample. Results 
from our study support the notion that RSA is a viable biomarker associated with future 
development of depressive symptoms in emerging adulthood. This holds promise for 
studies that seek to identify those at risk for depression and other forms of 
psychopathology.  
 
Limitations and Future Directions 
 
Although this study has several strengths, including the relatively large sample, 
examination of several covariates, and a longitudinal component, our findings should be 
interpreted in the context of several limitations. First, we acknowledge that BDI-II scores 
are only one measure of depressive symptoms and should not be viewed as a solitary tool 
to identify and diagnose depression. Thus, future research should look at BDI-II scores as 
only one measure in a multimethod approach for detecting and diagnosing depression. 
Second, RSA was measured at rest rather than during exposure to a stressor. Rottenberg 
(2005) provides evidence that differences may exist when examining the association 
between depressive symptoms and resting RSA when compared to RSA reactivity. 
Therefore, future research should examine a combination of RSA indices of physiological 
responses among depressed participants, as suggested by Yaroslavsky (2013). Third, this 
study looked at only one physiological index (i.e., resting RSA) as a predictor of 
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depressive symptoms, but perhaps accounting for multiple physiological indices would 
produce different findings.  
Fourth, while the objective of the current study was to examine associations in 
resting RSA and depression among college students, participants recruited for this study 
are in a life stage characterized by unique stressors. Thus, findings may not generalize to 
other developmental stages or to individuals not facing the particular stressors of a 
college student. Further, given the large number of participants in this sample who report 
minimal to mild depressive symptoms, the present data may not extend to individuals in 
the general population who report more moderate to severe depressive symptoms. Fifth, 
there was a high attrition rate in this sample due to participants graduating and/or moving 
out of state. However, analyses indicate participants with higher depressive symptoms 
were less likely to return for Y2. This introduced a conservative bias into our analyses. 
Despite this high attrition rate, results from this Y2 sample (i.e., lower reported 
depressive symptom severity compared to Y1 average) show that lower resting RSA was 
still associated with higher depressive symptoms over time.  
Finally, although it is important to consider biological vulnerabilities in the 
development of psychopathology, it is only one level of analysis among many factors that 
could affect risk for depression. According to Beauchaine and colleagues (2008), 
biological vulnerabilities may moderate the association between environment and 
behavioral adjustment. That is, when individuals are exposed to environmental risks, 
higher RSA serves as a protective factor from psychopathology development. In this 
study, environmental factors that may have influenced the development of depressive 
symptoms over a 12-month period were not assessed. Examples of these potentially 
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important environmental factors include perceived social support from family members 
or peers, and frequency and severity of stressful events. Future research should continue 
assessing biology × environment interactions in examining the etiology and maintenance 
of depressive symptoms over time.  
Additionally, since depression is characterized by a variety of presenting 
symptoms, future work should closely examine these individual symptoms of depression 
and how they are associated with resting RSA. Research by Rottenberg and colleagues 
(2002) indicates that particular depressive symptoms such as crying and sadness were 
associated with higher levels of RSA while suicidal ideation was associated with lower 
levels of RSA. Further, associations between resting RSA and depressive symptoms may 
change depending on one or more specific depressive symptoms rather than overall 
symptom severity. Perhaps further examination of symptom heterogeneity will provide 
answers as to why prior associations between RSA and depressive symptoms have 
produced mixed results.  
 
Implications for Research and Treatment 
 
This study expands upon previous research examining associations between 
resting RSA and depressive symptoms in smaller, cross-sectional samples. By including a 
larger sample of participants across a 12-month period, we are able to assess longitudinal 
associations within our variables of interest. Similar to previous findings that have 
documented resting RSA stability in samples of children and adults, RSA appears to be a 
fairly stable index of parasympathetic activity in emerging adults. In order to explore 
reasons for mixed findings regarding the association between RSA and depressive 
symptoms, researchers have begun to examine potential confounding variables. By 
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assessing multiple potential confounds, the relation between resting RSA and depressive 
symptoms in our study is likely not due to effects of age, BMI, medication use, or 
symptoms of anxiety. Results from this study suggest that resting RSA may be a viable 
prospective biomarker of depressive symptoms.  
This has potential implications for preventing later depression. For example, two 
studies found that biofeedback increased RSA and reduced depressive symptoms in 
individuals with PTSD (Zucker, Samuelson, Muench, Greenberg, & Gevirtz, 2009) and 
in a group of post-cardiac surgery patients (Patron et al., 2012). Vagus nerve stimulation 
has also been proposed as a treatment for chronic, treatment-resistant depression. Berry 
and colleagues (2013) conducted a meta-analysis which provides some evidence that 
there is a significant and lasting difference in response and remission rates between 
treatment resistant, depressed individuals in the intervention group (i.e., vagal nerve 
stimulation therapy) compared to the treatment as usual group. 
Further, psychological interventions targeted towards decreasing depressive 
symptoms may be a promising direction to pursue. For example, behavioral activation 
therapy (BA) is a well-established treatment for depression (Dimidjian et al., 2006; 
Jacobson et al., 1996); however, there is a lack of research that examines whether BA or 
other effective interventions may increase resting RSA. Examining increases in RSA 
from biological and psychological intervention approaches may shed more light on the 
association between RSA and depressive symptoms. In sum, understanding biomarkers 
(e.g., RSA) as a potentially viable predictor of psychopathology may assist with 
identification of developing disorders and could ultimately serve as a means of early 
intervention for individuals at risk for depression. 
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